Advertisement
GLUE 外匯新聞
Monte Rosa Therapeutics Inks Strategic Collaboration With Roche To Develop Molecular Glue Degraders
Biotechnology company Monte Rosa Therapeutics, Inc. (GLUE) announced Tuesday it has entered into a strategic collaboration and licensing agreement with Roche Holding AG to discover and develop MGDs against targets in cancer and neurological diseases.
RTTNews
|
575天前
